8607 related articles for article (PubMed ID: 1906430)
1. Tumoricidal activity and cytokine secretion by tumor-infiltrating macrophages.
Brunda MJ; Sulich V; Wright RB; Palleroni AV
Int J Cancer; 1991 Jul; 48(5):704-8. PubMed ID: 1906430
[TBL] [Abstract][Full Text] [Related]
2. Synergistic induction of cytotoxicity in macrophages by murine interferon-gamma and biological response modifiers derived from microorganisms.
Nagao S; Sato K; Osada Y
Cancer Immunol Immunother; 1986; 23(1):41-5. PubMed ID: 3094943
[TBL] [Abstract][Full Text] [Related]
3. Tumoricidal alveolar macrophage and tumor infiltrating macrophage cell lines.
Palleroni AV; Varesio L; Wright RB; Brunda MJ
Int J Cancer; 1991 Sep; 49(2):296-302. PubMed ID: 1879973
[TBL] [Abstract][Full Text] [Related]
4. Modulation of lipopolysaccharide-induced cytokine gene expression in mouse bone marrow-derived macrophages by muramyl dipeptide.
Le Contel C; Temime N; Charron DJ; Parant MA
J Immunol; 1993 May; 150(10):4541-9. PubMed ID: 8482846
[TBL] [Abstract][Full Text] [Related]
5. Augmentation by priming with interferon-gamma of the binding of a muramyl dipeptide derivative to macrophages resulting in synergistic macrophage activation.
Nagao S; Sato K; Osada Y
Jpn J Cancer Res; 1987 Jan; 78(1):80-6. PubMed ID: 3102442
[TBL] [Abstract][Full Text] [Related]
6. Effect of cisplatin, lipopolysaccharide, muramyl dipeptide and recombinant interferon-gamma on murine macrophages in vitro. I. Macrophage-mediated tumor cell lysis.
Geetha B; Sodhi A
Nat Immun Cell Growth Regul; 1989; 8(2):100-7. PubMed ID: 2503714
[TBL] [Abstract][Full Text] [Related]
7. Synergistic activation by recombinant mouse interferon-gamma and muramyl dipeptide of tumoricidal properties in mouse macrophages.
Saiki I; Fidler IJ
J Immunol; 1985 Jul; 135(1):684-8. PubMed ID: 3923117
[TBL] [Abstract][Full Text] [Related]
8. Synergistic activation by lymphokines and muramyl dipeptide of tumoricidal properties in rat alveolar macrophages.
Sone S; Fidler IJ
J Immunol; 1980 Dec; 125(6):2454-60. PubMed ID: 7430635
[TBL] [Abstract][Full Text] [Related]
9. Muramyl dipeptide enhances osteoclast formation induced by lipopolysaccharide, IL-1 alpha, and TNF-alpha through nucleotide-binding oligomerization domain 2-mediated signaling in osteoblasts.
Yang S; Takahashi N; Yamashita T; Sato N; Takahashi M; Mogi M; Uematsu T; Kobayashi Y; Nakamichi Y; Takeda K; Akira S; Takada H; Udagawa N; Furusawa K
J Immunol; 2005 Aug; 175(3):1956-64. PubMed ID: 16034140
[TBL] [Abstract][Full Text] [Related]
10. Differential stimulation of macrophages for tumor cytostasis and monokine production.
Sarih M; Souvannavong V; Adam A
Cancer Lett; 1992 Jul; 64(3):187-94. PubMed ID: 1638511
[TBL] [Abstract][Full Text] [Related]
11. MDP(Lysyl)GDP, a nontoxic muramyl dipeptide derivative, inhibits cytokine production by activated macrophages and protects mice from phorbol ester- and oxazolone-induced inflammation.
Zunic M; Bahr GM; Mudde GC; Meingassner JG; Lam C
J Invest Dermatol; 1998 Jul; 111(1):77-82. PubMed ID: 9665390
[TBL] [Abstract][Full Text] [Related]
12. Tumor necrosis factor-alpha-dependent production of reactive nitrogen intermediates mediates IFN-gamma plus IL-2-induced murine macrophage tumoricidal activity.
Cox GW; Melillo G; Chattopadhyay U; Mullet D; Fertel RH; Varesio L
J Immunol; 1992 Nov; 149(10):3290-6. PubMed ID: 1431106
[TBL] [Abstract][Full Text] [Related]
13. Human alveolar macrophages: potentiation of their tumoricidal activity by liposome-encapsulated muramyl dipeptide.
Sone S; Tsubura E
J Immunol; 1982 Sep; 129(3):1313-7. PubMed ID: 7108208
[TBL] [Abstract][Full Text] [Related]
14. Enhanced superoxide production by rat alveolar macrophages stimulated in vitro with biological response modifiers.
Badger AM
J Leukoc Biol; 1986 Dec; 40(6):725-36. PubMed ID: 3023513
[TBL] [Abstract][Full Text] [Related]
15. Abrogation of species specificity for activation of tumoricidal properties in macrophages by recombinant mouse or human interferon-gamma encapsulated in liposomes.
Fidler IJ; Fogler WE; Kleinerman ES; Saiki I
J Immunol; 1985 Dec; 135(6):4289-96. PubMed ID: 3934281
[TBL] [Abstract][Full Text] [Related]
16. Interferon-gamma and tumor necrosis factor induce the L-arginine-dependent cytotoxic effector mechanism in murine macrophages.
Drapier JC; Wietzerbin J; Hibbs JB
Eur J Immunol; 1988 Oct; 18(10):1587-92. PubMed ID: 3142779
[TBL] [Abstract][Full Text] [Related]
17. [Immunostimulating effects of muramyl dipeptide, glucosaminyl muramyl dipeptide and their synthetic derivatives in vitro].
Rakhmilevich AL; Rakhimova MS; Andronova TM; Bovin NV
Antibiot Khimioter; 1989 Aug; 34(8):586-9. PubMed ID: 2589897
[TBL] [Abstract][Full Text] [Related]
18. [The immunomodulating activity of new muramyl dipeptide derivatives in vitro].
Medvedev AE; Fuks BB; Bovin NV; Zemliakov AE
Biull Eksp Biol Med; 1992 Dec; 114(12):626-8. PubMed ID: 1292694
[TBL] [Abstract][Full Text] [Related]
19. Upregulation of interferon-induced indoleamine 2,3-dioxygenase in human macrophage cultures by lipopolysaccharide, muramyl tripeptide, and interleukin-1.
Hissong BD; Byrne GI; Padilla ML; Carlin JM
Cell Immunol; 1995 Feb; 160(2):264-9. PubMed ID: 7720088
[TBL] [Abstract][Full Text] [Related]
20. Lack of response of murine peritoneal macrophages to in vitro activation by muramyl dipeptide (MDP). I. Macrophage activation by MDP is species dependent.
Nagao S; Akagawa KS; Yamada K; Yagawa K; Tokunaga T; Kotani S
Microbiol Immunol; 1990; 34(3):323-35. PubMed ID: 2352499
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
